Functional analysis of the polymorphism - 211C>T in the regulatory region of the human ABCC3 gene

Life Sciences

Volumn 80, Issue 16, 2007, Pages 1490-1494

  Gradhand, Ulrike ^a   Tegude, Heike ^b   Burk, Oliver ^b   Eichelbaum, Michel ^b   Fromm, Martin F ^a   König, Jörg ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b Institute of Clinical Pharmacology   (Germany)

Author keywords

ABCC3; FTF; MRP3; Multidrug resistance; Promoter; Regulation; SNP

Indexed keywords

CYTOSINE; LUCIFERASE; MULTIDRUG RESISTANCE PROTEIN 3; THYMINE;

ABCC3 GENE; ARTICLE; CONTROLLED STUDY; DNA POLYMORPHISM; GENE; GENE ACTIVITY; GENE CONSTRUCT; GENE CONTROL; GENE EXPRESSION; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; REPORTER GENE; RNA TRANSLATION; SINGLE NUCLEOTIDE POLYMORPHISM;

ANALYSIS OF VARIANCE; CLONING, MOLECULAR; DNA PRIMERS; GENES, REPORTER; HUMANS; LUCIFERASES; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; POLYMORPHISM, SINGLE NUCLEOTIDE; REGULATORY SEQUENCES, NUCLEIC ACID; TRANSFECTION;

EID: 33947122583     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2007.01.023     Document Type: Article

References (24)

1. Belinsky M.G., Dawson P.A., Shchaveleva I., Bain L.J., Wang R., Ling V., Chen Z.S., Grinberg A., Westphal H., Klein-Szanto A., Lerro A., and Kruh G.D. Analysis of the in vivo functions of Mrp3. Molecular Pharmacology 68 1 (2005) 160-168
2. Bohan A., Chen W.S., Denson L.A., Held M.A., and Boyer J.L. Tumor necrosis factor alpha-dependent up-regulation of Lrh-1 and Mrp3(Abcc3) reduces liver injury in obstructive cholestasis. Journal of Biological Chemistry 278 38 (2003) 36688-36698
3. Borst P., Evers R., Kool M., and Wijnholds J. A family of drug transporters: the multidrug resistance-associated proteins. Journal of the National Cancer Institute 92 16 (2000) 1295-1302
4. Borst P., de Wolf C., and van de Wetering K. Multidrug resistance-associated proteins 3, 4, and 5. Pflügers Archiv 453 5 (2007) 661-673
5. Doerfel C., Rump A., Sauerbrey A., Gruhn B., Zintl F., and Steinbach D. In acute leukemia, the polymorphism - 211C>T in the promoter region of the multidrug resistance-associated protein 3 (MRP3) does not determine the expression level of the gene. Pharmacogenetics and Genomics 16 2 (2006) 149-150
6. Galarneau L., Pare J.F., Allard D., Hamel D., Levesque L., Tugwood J.D., Green S., and Belanger L. The alpha1-fetoprotein locus is activated by a nuclear receptor of the Drosophila FTZ-F1 family. Molecular and Cellular Biology 16 7 (1996) 3853-3865
7. Geick A., Eichelbaum M., and Burk O. Nuclear receptor response elements mediate induction of intestinal MDR1 by rifampin. Journal of Biological Chemistry 276 18 (2001) 14581-14587
8. Hirohashi T., Suzuki H., and Sugiyama Y. Characterization of the transport properties of cloned rat multidrug resistance-associated protein 3 (MRP3). Journal of Biological Chemistry 274 21 (1999) 15181-15185
9. Hirohashi T., Suzuki H., Takikawa H., and Sugiyama Y. ATP-dependent transport of bile salts by rat multidrug resistance-associated protein 3 (Mrp3). Journal of Biological Chemistry 275 4 (2000) 2905-2910
10. Inokuchi A., Hinoshita E., Iwamoto Y., Kohno K., Kuwano M., and Uchiumi T. Enhanced expression of the human multidrug resistance protein 3 by bile salt in human enterocytes. A transcriptional control of a plausible bile acid transporter. Journal of Biological Chemistry 276 50 (2001) 46822-46829
11. König J., Rost D., Cui Y., and Keppler D. Characterization of the human multidrug resistance protein isoform MRP3 localized to the basolateral hepatocyte membrane. Hepatology 29 4 (1999) 1156-1163
12. König J., Nies A.T., Cui Y., Leier I., and Keppler D. Conjugate export pumps of the multidrug resistance protein (MRP) family: localization, substrate specificity, and MRP2-mediated drug resistance. Biochimica et Biophysica Acta. Biomembranes 1461 2 (1999) 377-394
13. Kruh G.D., and Belinsky M.G. The MRP family of drug efflux pumps. Oncogene 22 47 (2003) 7537-7552
14. Lang T., Hitzl M., Burk O., Mornhinweg E., Keil A., Kerb R., Klein K., Zanger U.M., Eichelbaum M., and Fromm M.F. Genetic polymorphisms in the multidrug resistance-associated protein 3 (ABCC3, MRP3) gene and relationship to its mRNA and protein expression in human liver. Pharmacogenetics 14 3 (2004) 155-164
15. Lee Y.M., Cui Y., König J., Risch A., Jäger B., Drings P., Bartsch H., Keppler D., and Nies A.T. Identification and functional characterization of the natural variant MRP3-Arg1297His of human multidrug resistance protein 3 (MRP3/ABCC3). Pharmacogenetics 14 4 (2004) 213-223
16. Ogawa K., Suzuki H., Hirohashi T., Ishikawa T., Meier P.J., Hirose K., Akizawa T., Yoshioka M., and Sugiyama Y. Characterization of inducible nature of MRP3 in rat liver. American Journal of Physiology: Gastrointestinal and Liver Physiology 278 3 (2000) G438-G446
17. Risch A., Müller P., Asher N., Bar-Cohen S., Bartsch H., and Rund D. Polymorphisms in transporter genes and chemotherapy response in acute myeloid leukemia (AML) patients from Israel. 47th Spring Meeting of the German Society of Experimental and Clinical Pharmacology and Toxicology, Mainz, Germany, April 4-6, 2006. Naunyn-Schmiedeberg's Archives of Pharmacology vol. 372 (supplement 1) (2006) 144 abstract
18. Rost D., König J., Weiss G., Klar E., Stremmel W., and Keppler D. Expression and localization of the multidrug resistance proteins MRP2 and MRP3 in human gallbladder epithelia. Gastroenterology 121 5 (2001) 1203-1208
19. Scheffer G.L., Kool M., de Haas M., de Vree J.M., Pijnenborg A.C., Bosman D.K., Elferink R.P., van der Valk P., Borst P., and Scheper R.J. Tissue distribution and induction of human multidrug resistant protein 3. Laboratory Investigation 82 2 (2002) 193-201
20. Zamek-Gliszczynski M.J., Nezasa K.I., Tian X., Bridges A.S., Lee K., Belinsky M.G., Kruh G.D., and Brouwer K.L. Evaluation of the role of multidrug resistance-associated protein (Mrp) 3 and Mrp4 in hepatic basolateral excretion of sulfate and glucuronide metabolites of acetaminophen, 4-methylumbelliferone, and harmol in Abcc3-/- and Abcc4-/- Mice. Journal of Pharmacology and Experimental Therapeutics 319 3 (2006) 1485-1491
21. Zelcer N., Saeki T., Reid G., Beijnen J.H., and Borst P. Characterization of drug transport by the human multidrug resistance protein 3 (ABCC3). Journal of Biological Chemistry 276 49 (2001) 46400-46407
22. Zelcer N., van de Wetering K., Hillebrand M., Sarton E., Kuil A., Wielinga P.R., Tephly T., Dahan A., Beijnen J.H., and Borst P. Mice lacking multidrug resistance protein 3 show altered morphine pharmacokinetics and morphine-6-glucuronide antinociception. Proceedings of the National Academy of Sciences of the United States of America 102 20 (2005) 7274-7279
23. Zelcer N., van de Wetering K., de Waart R., Scheffer G.L., Marschall H.U., Wielinga P.R., Kuil A., Kunne C., Smith A., van der Valk M., Wijnholds J., Elferink R.O., and Borst P. Mice lacking Mrp3 (Abcc3) have normal bile salt transport, but altered hepatic transport of endogenous glucuronides. Journal of Hepatology 44 4 (2006) 768-775
24. Zeng H., Bain L.J., Belinsky M.G., and Kruh G.D. Expression of multidrug resistance protein-3 (multispecific organic anion transporter-D) in human embryonic kidney 293 cells confers resistance to anticancer agents. Cancer Research 59 23 (1999) 5964-5967